Work

In utero treatment of myelomeningocele with placental mesenchymal stromal cells — Selection of an optimal cell line in preparation for clinical trials

Year: 2019

Type: article

Source: Journal of Pediatric Surgery

DOI: 10.1016/j.jpedsurg.2019.09.029

Authors: Laura A Galganski, Priyadarsini Kumar, Melissa A Vanover, Christopher D Pivetti, Jamie E Anderson, Lee Lankford, Zachary J Paxton, Karen Chung, Chelsey Lee, Mennatalla S Hegazi, Kaeli J Yamashiro, Aijun Wang, Diana L Farmer

Institutions: University of California, Davis, Shriners Hospitals for Children - Northern California

Language: English

Topic: Spinal Dysraphism and Malformations

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Foundation for the National Institutes of Health, California Institute for Regenerative Medicine, March of Dimes Foundation, California Institute of Regenerative Medicine, Shriners Hospitals for Children, National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: Guinea pigs as a model of in utero stem cell therapy for spina bifida, G4139584552, Fetal Tissue Engineering to Treat Spina Bifida Before Birth, G4266307509, Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida Therapy, G5852404115, G711076770, G8901401789, UC Davis Clinical and Translational Science Center

OpenAlex ID: W2981622262

FWCI: 4.264

Cites: 40

Cited by: 31

Related to: 10